2 results
Approved WMOCompleted
The objectives of this study are to compare the safety and efficacy of 2 annual cycles of intravenous (IV) alemtuzumab to 3-times weekly subcutaneous (SC) interferon beta 1a (Rebif*) in patients with active relapsing-remitting multiple sclerosis (…
Approved WMOCompleted
The primary objective is to determine the feasibility of applying CPC-PLGA in sinus floor elevation surgery in terms of bone formation and implant survival. The secondary objective is to investigate pain, health-related quality of life and the…